Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules

Pharmaceutical Technology


People
Cook, ABB, Tyco, and Mettler-Toledo Gain New Managment

Cook Pharmica (Bloomington, IN), the contract biopharmaceutical manufacturing division of Cook Medical, named Connie Degen vice-president of operations and Tedd Green vice-president of business operations and chief financial officer.

Degen will direct and oversee all activities of manufacturing, maintenance, manufacturing sciences, and engineering. Green will provide overall strategic leadership by overseeing Cook's fiscal, human resource, project management, business development, marketing programs, policies, and services.

ABB (Zurich, Switzerland) appointed Enrique Santacana as region manager, ABB North America and president and CEO of ABB Inc. USA. Most recently, he was ABB's region division manager for power products in North America.

Tyco International Ltd. (Princeton, NJ) appointed Patrick Decker president of Tyco Flow Control, a business segment of Tyco and provider of flow-control products. Decker joined Tyco in May 2003 as the chief financial officer of Tyco's plastics and adhesives business.

Robert Scott was named the new product manager for X-ray inspection at Mettler-Toledo Safeline (Tampa, FL). Scott will oversee the sale and commissioning of all X-ray units in the Americas.

Standards
US Pharmacopeia Lists EUDRAGIT Polymers

The US Pharmacopeia (Rockville, MD) plans to list monographs of Degussa's (Parsippany, NJ) "EUDRAGIT NE 30 D" and "EUDRAGIT E 100" acrylic polymers in its US Pharmacopeia–National Formulary (USP–NF) beginning Aug. 1. The monographs are titled "Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion" and "Amino Methacrylate Copolymer," respectively.

Collaboration
JRS Pharma and CoreRx to Develop Coprocessed APIs

JRS Pharma LP (Patterson, NY) and CoreRx Pharmaceuticals (Tampa, FL) signed a collaboration agreement, whereby CoreRx will conduct formulation and development work for drugs that have been coprocessed using JRS Pharma's "PROSOLV" technology. The agreement involves investigation of the performance and stability enhancement of generic drug candidates, including cardiovascular, anti-infectives, and anticancer therapies.

Envirotainer, Continental Offer Cold-Chain Services

Envirotainer (Stockholm, Sweden) and Continental Airlines Cargo (Houston, TX) signed a global contract to expand a product line featuring Envirotainer's temperature-controlled, air-cargo containers. The containers are designed as alternatives to traditional cooling methods such as foams and gel packs.

Environtainer recently announced it will focus solely on serving the pharmaceutical industry with various transport solutions, temperature-controlled systems, and cold-chain containers.

Expansion
Dow to Boost PEG Capacity

The Dow Chemical Company (Midland, MI) plans to increase production capacity for its solid-grad "Carbowax Sentry" polyethylene glycols (PEGs) at its St. Charles operations in Hahnville, Louisiana. The company is targeting an increase of about 30% before the end of 2008.

The company's PEG materials are produced in accordance with current good manufacturing practices regulations and meet requirements stated in the US Pharmacopeia–National Formulary, European Pharmacopoeia, and Food Chemicals Codex.

Acquisition
Clondalkin Group Acquires Keller Crescent


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here